Euglycemic Diabetic Ketoacidosis Triggered by Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Use in a Patient With Type 2 Diabetes Mellitus. Here, SLC5A2 is linked to type 2 diabetes mellitus.